Crossing Atheroma or Thrombus With ByCross Device for Revascularization of Peripheral Arteries of Diameter ≥ 3mm

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

July 1, 2019

Study Completion Date

October 9, 2019

Conditions
Arterial Occlusive Diseases
Interventions
DEVICE

ByCross Atherectomy and Thrombectomy

"After assessment of the lesion by angiography the ByCross is advanced over a 0.035 guidewire through a sheath to the occlusion. Activation will rotate the shaft and start aspiration. Under fluoroscopy the ByCross is advanced continuously over the wire. in case passage is not possible the ByCross tip is advanced into the occlusion for 10mm, then wire is advanced to check is passage is possible, this is repeated until passage by the wire is achieved. At harder lesion the speed is set to high. Once the occlusion is crossed the ByCross tip is enlarged, device is advanced once more to increase opening. Additional adjunctive treatment may be performed per physician's discretion and according to standard of care. Performance criteria of the intervention is to achieved more than 70% opening."

Trial Locations (2)

40472

Augusta-Krankenhaus, Düsseldorf

49808

Bonifatius Hospital Lingen, Lingen

All Listed Sponsors
lead

Taryag Medical Ltd.

INDUSTRY

NCT03724279 - Crossing Atheroma or Thrombus With ByCross Device for Revascularization of Peripheral Arteries of Diameter ≥ 3mm | Biotech Hunter | Biotech Hunter